Clinical Trial of an Oxytocin‐Ergometrine Mixture

Standpoint of reducing the amount of bleeding, the value of administering an oxytocic agent intravenously at the end of the second stage of labour has long been established (Adair et al., 1935). It has also repeatedly been shown that, although both are safe, ergometrine is more effective than oxytocin (Lister, 1950).